Abstract
Background: Stellera chamaejasme is a perennial weed and is found across a wide geographic range. It is found in the Altai of eastern Russia, northern China and Mongolia southwards and reaches as far as the western Himalayas of the Qinghai-Tibet and Yungui Plateaus. The dried roots of S. Chamaejasme are named “Rui- Xiang-Lang-Du” and this herb with toxic properties is widely used in Traditional Chinese Medicine for the treatment of various disorders. It is effective against dispelling phlegm by water and displays toxicity against insect pests. This review provides a comprehensive overview of the chemical composition and the pharmacological properties of S. Chamaejasme thus providing a better insight into its application in the prevention of human disease.
Methods: A comprehensive literature review was undertaken and the main chemical compounds found in S. Chamaejasme were identified on the basis of their chemical formula and structure. These included flavonoids, coumarins, lignans, diterpenoids plus others, and their pharmacological properties were also summarized in detail.
Results: The main constituents of S. Chamaejasme included flavonoids, coumarins, lignans, diterpenoids plus other compounds. The pharmacological properties of these compounds displayed a wide spectrum and include anti-tumors, anti-viral, anti-bacterial, anti-convulsive, anti-epileptic, insecticide, anti-inflammation, regulation of immunity etc. The diterpenoids were widely recognized as the constituent responsible for the anti-tumor effect.
Conclusion: A large number of studies conclude that S. Chamaejasme displays a wide spectrum of pharmacological activity with the anti-tumor activity being significant.
Keywords: Stellera chamaejasme, chinese herbal medicine, chemical compositions, analytical method, pharmacological activities, toxicity.
Current Pharmaceutical Design
Title:Chemical Constituents and Pharmacological Activities of Stellera chamaejasme
Volume: 24 Issue: 24
Author(s): Xiao-Qin Li, Khalid Rahman, Jian-Yong Zhu*Hong Zhang*
Affiliation:
- Central Laboratory, Seventh People's Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai,China
- Central Laboratory, Seventh People's Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai,China
Keywords: Stellera chamaejasme, chinese herbal medicine, chemical compositions, analytical method, pharmacological activities, toxicity.
Abstract: Background: Stellera chamaejasme is a perennial weed and is found across a wide geographic range. It is found in the Altai of eastern Russia, northern China and Mongolia southwards and reaches as far as the western Himalayas of the Qinghai-Tibet and Yungui Plateaus. The dried roots of S. Chamaejasme are named “Rui- Xiang-Lang-Du” and this herb with toxic properties is widely used in Traditional Chinese Medicine for the treatment of various disorders. It is effective against dispelling phlegm by water and displays toxicity against insect pests. This review provides a comprehensive overview of the chemical composition and the pharmacological properties of S. Chamaejasme thus providing a better insight into its application in the prevention of human disease.
Methods: A comprehensive literature review was undertaken and the main chemical compounds found in S. Chamaejasme were identified on the basis of their chemical formula and structure. These included flavonoids, coumarins, lignans, diterpenoids plus others, and their pharmacological properties were also summarized in detail.
Results: The main constituents of S. Chamaejasme included flavonoids, coumarins, lignans, diterpenoids plus other compounds. The pharmacological properties of these compounds displayed a wide spectrum and include anti-tumors, anti-viral, anti-bacterial, anti-convulsive, anti-epileptic, insecticide, anti-inflammation, regulation of immunity etc. The diterpenoids were widely recognized as the constituent responsible for the anti-tumor effect.
Conclusion: A large number of studies conclude that S. Chamaejasme displays a wide spectrum of pharmacological activity with the anti-tumor activity being significant.
Export Options
About this article
Cite this article as:
Li Xiao-Qin , Rahman Khalid , Zhu Jian-Yong *, Zhang Hong*, Chemical Constituents and Pharmacological Activities of Stellera chamaejasme, Current Pharmaceutical Design 2018; 24 (24) . https://dx.doi.org/10.2174/1381612824666180903110802
DOI https://dx.doi.org/10.2174/1381612824666180903110802 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
An Overview of the α4β1 Integrin and the Potential Therapeutic Role of its Antagonists
Current Medicinal Chemistry Synthetic Lethal Interactions in Cancer Therapy
Current Cancer Drug Targets Uric Acid and Hypertension
Current Pharmaceutical Design Patents in Cancer Stem Cells
Recent Patents on Biomarkers The Bcl-2 Family as a Rational Target for the Treatment of B-Cell Chronic Lymphocytic Leukaemia
Current Medicinal Chemistry A Comparison of the Inhibitory Effects of Anti-Cancer Drugs on Thioredoxin Reductase and Glutathione S-Transferase in Rat Liver
Anti-Cancer Agents in Medicinal Chemistry Long Non-Coding RNA: An Emerging Paradigm of Pancreatic Cancer
Current Molecular Medicine Ganoderma lucidum (Ling-zhi): The Impact of Chemistry on Biological Activity in Cancer
Current Bioactive Compounds Progress in Cationic Lipid-Mediated Gene Transfection: A Series of Bio- Inspired Lipids as an Example
Current Gene Therapy Synthesis, SAR and Biological Evaluation of Natural and Non-natural Hydroxylated and Prenylated Xanthones as Antitumor Agents
Medicinal Chemistry DNA Demethylation by TET Proteins: A Potential Therapeutic Target in Cancer
Epigenetic Diagnosis & Therapy (Discontinued) Vitamin D Analogs as Anti-Carcinogenic Agents
Anti-Cancer Agents in Medicinal Chemistry Editorial [Hot topic: The Urokinase Receptor System as Strategic Therapeutic Target: Challenges for the 21st Century (Executive Guest Editor: Bernard Degryse)]
Current Pharmaceutical Design Insights into the Role of Fc Gamma Receptors (FcγRs) Genetic Variations in Monoclonal Antibody-Based Anti-Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Chemical Origins of Isoform Selectivity in Histone Deacetylase Inhibitors
Current Pharmaceutical Design Clinical Development of Inhibitors of the Insulin-like Growth Factor Receptor in Oncology
Current Drug Targets Synthesis and Anticancer Activity of Phthalimido and Naphthalimido Substituted Dihydropyrimidone Conjugates
Letters in Drug Design & Discovery Editorial [Hot Topic: SOD Enzymes and Their Mimics in Cancer:Pro- vs Anti-Oxidative Mode of Action-Part II (Guest Editor: Ines Batinic-Haberle)]
Anti-Cancer Agents in Medicinal Chemistry MicroRNA Dysregulation in the Myelodysplastic Syndromes
MicroRNA Cyclophilin function in Cancer; lessons from virus replication
Current Molecular Pharmacology